Nova Eye Medical Limited (ASX:EYE)
Australia
· Delayed Price · Currency is AUD 0.1300
+0.0100 (8.33%)
May 9, 2025, 4:10 PM AEST
Nova Eye Medical Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 26.11 | 23.33 | 17.03 | 13.38 | 13.39 | 12.77 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.05 | Upgrade
|
| Revenue | 26.11 | 23.33 | 17.03 | 13.38 | 13.39 | 12.82 | Upgrade
|
| Revenue Growth (YoY) | 39.08% | 37.00% | 27.26% | -0.12% | 4.51% | -20.59% | Upgrade
|
| Cost of Revenue | 4.3 | 3.13 | 2.63 | 2.29 | 2.24 | 3.02 | Upgrade
|
| Gross Profit | 21.81 | 20.19 | 14.39 | 11.09 | 11.15 | 9.79 | Upgrade
|
| Selling, General & Admin | 24.89 | 23.42 | 21.87 | 17.4 | 13.21 | 14.25 | Upgrade
|
| Research & Development | -0.21 | - | - | - | - | - | Upgrade
|
| Other Operating Expenses | 2.84 | 2.75 | 2.01 | 1.58 | 1.39 | 1.23 | Upgrade
|
| Operating Expenses | 30.5 | 29.16 | 26.17 | 20.79 | 16.12 | 16.92 | Upgrade
|
| Operating Income | -8.69 | -8.97 | -11.78 | -9.7 | -4.97 | -7.12 | Upgrade
|
| Interest Expense | -0.1 | -0.07 | -0.05 | -0.06 | -0.07 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.12 | 0.1 | 0.03 | 0.24 | 0.05 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.39 | -0.39 | 0.14 | -0.05 | -0.48 | -0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.51 | 0.51 | 0.63 | 0.54 | 0.03 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -8.56 | -8.79 | -10.96 | -9.24 | -5.25 | -7.28 | Upgrade
|
| Asset Writedown | - | - | -6.04 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.42 | - | 0.03 | Upgrade
|
| Pretax Income | -8.56 | -8.79 | -17 | -7.82 | -5.25 | -7.25 | Upgrade
|
| Income Tax Expense | - | - | -1.71 | -0.32 | -0.89 | 3.08 | Upgrade
|
| Earnings From Continuing Operations | -8.56 | -8.79 | -15.29 | -7.5 | -4.36 | -10.33 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | 45.98 | Upgrade
|
| Net Income | -8.56 | -8.79 | -15.29 | -7.5 | -4.36 | 35.65 | Upgrade
|
| Net Income to Common | -8.56 | -8.79 | -15.29 | -7.5 | -4.36 | 35.65 | Upgrade
|
| Shares Outstanding (Basic) | 224 | 204 | 156 | 145 | 144 | 144 | Upgrade
|
| Shares Outstanding (Diluted) | 224 | 204 | 156 | 145 | 144 | 144 | Upgrade
|
| Shares Change (YoY) | 25.32% | 30.89% | 7.83% | 0.69% | 0.03% | - | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 | 0.25 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.10 | -0.05 | -0.03 | 0.25 | Upgrade
|
| Free Cash Flow | -7.38 | -8.07 | -7.09 | -4.85 | -13.53 | 5.14 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.04 | -0.04 | -0.03 | -0.09 | 0.04 | Upgrade
|
| Gross Margin | 83.53% | 86.57% | 84.55% | 82.89% | 83.25% | 76.42% | Upgrade
|
| Operating Margin | -33.28% | -38.45% | -69.19% | -72.50% | -37.07% | -55.58% | Upgrade
|
| Profit Margin | -32.78% | -37.69% | -89.83% | -56.03% | -32.52% | 278.19% | Upgrade
|
| Free Cash Flow Margin | -28.24% | -34.59% | -41.63% | -36.27% | -100.99% | 40.08% | Upgrade
|
| EBITDA | -5.73 | -5.98 | -9.48 | -7.89 | -3.45 | -5.68 | Upgrade
|
| EBITDA Margin | -21.93% | -25.63% | -55.69% | -58.96% | -25.76% | -44.35% | Upgrade
|
| D&A For EBITDA | 2.97 | 2.99 | 2.3 | 1.81 | 1.52 | 1.44 | Upgrade
|
| EBIT | -8.69 | -8.97 | -11.78 | -9.7 | -4.97 | -7.12 | Upgrade
|
| EBIT Margin | -33.28% | -38.45% | -69.19% | -72.50% | -37.07% | -55.58% | Upgrade
|
| Advertising Expenses | - | 3.04 | 3.2 | 1.78 | 0.73 | 0.67 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.